THE MACRIMASA GROUP’S SUSTAINABILITY POLICY
In December 2020, the Board of Directors of the Macrimasa Group approved the Sustainability Policy in order to establish the basic and specific principles of action of Macrimasa and the companies of the Group in this matter, as well as in the relationship of the Group with its environment and stakeholders.
The Macrimasa Group defines stakeholders as those groups that have the capacity to influence the achievement of the organisation’s objectives. Among these, the following stand out:
• customers,
• employees,
• suppliers,
• shareholders,
and the users of the health system, who benefit from its policies related to:
• quality
• innovation
• social action
• the environment.
The basic principles of action of the Macrimasa Group in relation to its stakeholders and the environment are based on compliance with national and international laws and regulations in force in the countries in which it operates, as well as compliance with international commitments related to sustainability, voluntarily subscribed to by the Macrimasa Group. Furthermore, the Group undertakes to carry out all its activities in accordance with the fundamental principles of transparency, ethics and integrity.
This division focuses on the research, development and marketing of Medical Healthcare Technology, which markets medical devices, diagnostic systems and reagents whose main objective is to improve people's health in the hospital environment.
At present, we are constantly working on the research and development of products for the veterinary sector. Our aim is to provide real solutions to the new needs of animal health. The constant communication with the veterinary clinician helps us to carry out this work.
Medical Technology Division that commercialises material for aesthetic medicine centres and hospitals, geriatric centres, assisted reproduction units, emergency, rescue and diagnosis, whose main objective is to guarantee the reliability of the values of our products.
MACRIMASA ACADEMY is the MACRIMASA GROUP's digital innovation centre that contributes to the development of new digital capabilities to help demonstrate, transfer and share knowledge to our clients, based on its skill centres focused on digital technologies and their applicability to medical and business results.
MACRIMASA HUB promotes an Open Innovation programme to accelerate innovation in the era of disruption It is the first corporate accelerator of human and animal health startups in Spain Through open and collaborative innovation, we explore the co-creation of solutions and new sustainable value propositions to the strategic challenges of the company and the challenges of the different business units of the company through the combination of internal knowledge and the capabilities provided by the best startups. The startups that participate in the I'MNOVATION programme co-develop pilot projects together with experts from the company for three months for their validation in real market environments, a period in which they have the collaboration, mentoring and financing of the MACRIMASA GROUP for their execution.
